|
AP2040B-ev
|
Abcepta, Inc.
|
TAU [C-term] [RB2883], Rabbit Polyclonal Antibody
|
Human, Mouse, Rat, Cynomolgus Monkey
|
WB, IF, IHC-P
|
|
|
AP2040B
|
Abcepta, Inc.
|
TAU [C-term] [RB2883], Rabbit Polyclonal Antibody
|
Human, Mouse, Rat, Cynomolgus Monkey
|
WB, IF, IHC-P
|
|
|
AP1425c-ev
|
Abcepta, Inc.
|
TAU [MAPT] [S720] [RB11005], Rabbit Polyclonal Antibody
|
Human, Cynomolgus Monkey
|
WB, IHC-P, IHC
|
|
|
AP1425c
|
Abcepta, Inc.
|
TAU [MAPT] [S720] [RB11005], Rabbit Polyclonal Antibody
|
Human, Cynomolgus Monkey
|
WB, IHC-P, IHC
|
|
|
AM8586b-ev
|
Abcepta, Inc.
|
USP2 [1738CT331.50.87], Mouse Monoclonal Antibody
|
Human, African Green Monkey
|
WB
|
|
|
AM8586b
|
Abcepta, Inc.
|
USP2 [1738CT331.50.87], Mouse Monoclonal Antibody
|
Human, African Green Monkey
|
WB
|
|
|
AM2231b-ev
|
Abcepta, Inc.
|
YY1 [1183CT6.5.23.6], Mouse Monoclonal Antibody
|
Human, Rat, Zebrafish, Cynomolgus Monkey
|
WB, IHC-P
|
|
|
AM2231b
|
Abcepta, Inc.
|
YY1 [1183CT6.5.23.6], Mouse Monoclonal Antibody
|
Human, Rat, Zebrafish, Cynomolgus Monkey
|
WB, IHC-P
|
|
|
ATGL0019-100ug
|
NKMax Bio (ATGen)
|
U-87 MG Cell Lysate
|
Human
|
WB
|
|
|
ATGL0019-500ug
|
NKMax Bio (ATGen)
|
U-87 MG Cell Lysate
|
Human
|
WB
|
|
|
TA308398
|
OriGene Technologies
|
BZW2, Rabbit Polyclonal Antibody
|
Human (Predicted: Rhesus Monkey)
|
IF, IHC, WB
|
|
|
TA308248
|
OriGene Technologies
|
FBXL3, Rabbit Polyclonal Antibody
|
Human (Predicted: Rhesus Monkey, Rat, Sheep)
|
IF, WB
|
|
|
TA308367
|
OriGene Technologies
|
GAD65 (GAD2), Rabbit Polyclonal Antibody
|
Human, Mouse (Predicted: Rhesus Monkey)
|
IF, IHC, WB
|
|
|
TA308785
|
OriGene Technologies
|
GAD65 (GAD2), Rabbit Polyclonal Antibody
|
Human, Mouse (Predicted: Rhesus Monkey, Dog, Pig)
|
IHC, WB
|
|
|
TA308278
|
OriGene Technologies
|
GADD45G, Rabbit Polyclonal Antibody
|
Human (Predicted: Bovine, Mouse, Rhesus Monkey, Rat, X. tropicalis, Pig)
|
IF, WB
|
|
|
TA308121
|
OriGene Technologies
|
JPT1, Rabbit Polyclonal Antibody
|
Human (Predicted: Monkey, Mouse, Rat, Dog, Cow)
|
WB
|
|
|
HY-10198-10mg
|
MedChemexpress LLC
|
Navarixin [CAS 473727-83-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-10198-100mg
|
MedChemexpress LLC
|
Navarixin [CAS 473727-83-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-10198-5mg
|
MedChemexpress LLC
|
Navarixin [CAS 473727-83-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-10198-50mg
|
MedChemexpress LLC
|
Navarixin [CAS 473727-83-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-10198-1mL
|
MedChemexpress LLC
|
Navarixin [CAS 473727-83-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-12798A-10mg
|
MedChemexpress LLC
|
Netarsudil (dimesylate) [CAS 1422144-42-0]
|
|
|
|
|
HY-12798A-100mg
|
MedChemexpress LLC
|
Netarsudil (dimesylate) [CAS 1422144-42-0]
|
|
|
|
|
HY-12798A-5mg
|
MedChemexpress LLC
|
Netarsudil (dimesylate) [CAS 1422144-42-0]
|
|
|
|
|
HY-12798A-50mg
|
MedChemexpress LLC
|
Netarsudil (dimesylate) [CAS 1422144-42-0]
|
|
|
|
